Stockscreener 앱 받기
1.25
1.57%
-0.02
시간 외 거래:
1.25
전일 마감가:
$1.27
열려 있는:
$1.29
하루 거래량:
389.36K
Relative Volume:
0.29
시가총액:
$23.84M
수익:
-
순이익/손실:
$-11.24M
주가수익비율:
-1.6415
EPS:
-0.7615
순현금흐름:
$-4.79M
1주 성능:
-13.79%
1개월 성능:
-11.97%
6개월 성능:
+4.17%
1년 성능:
+7.76%
1일 변동 폭
$1.24
$1.29
1주일 범위
$1.1936
$1.47
52주 변동 폭
$0.73
$2.56
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
명칭
Mira Pharmaceuticals Inc
전화
813-369-5150
주소
1200 BRICKELL AVENUE, MIAMI
MIRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.25 | 24.22M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
751.99 | 683.93B | 53.26B | 13.80B | -50.20M | 15.30 |
|
JNJ
Johnson Johnson
|
176.19 | 419.44B | 90.62B | 22.66B | 18.18B | 9.35 |
|
ABBV
Abbvie Inc
|
222.47 | 392.16B | 58.33B | 3.73B | 18.24B | 2.10 |
|
NVS
Novartis Ag Adr
|
122.93 | 236.74B | 53.40B | 13.68B | 16.89B | 6.9231 |
|
NVO
Novo Nordisk Adr
|
61.40 | 274.83B | 45.44B | 16.18B | 9.21B | 3.634 |
Mira Pharmaceuticals Inc 주식(MIRA)의 최신 뉴스
Earnings visualization tools for MIRA Pharmaceuticals Inc.Insider Buying & Safe Capital Investment Plans - newser.com
Fed Watch: Is MIRA Pharmaceuticals Inc stock technically oversoldWeekly Trade Review & Community Consensus Trade Signals - khodrobank.com
Market Overview: Can VRTS scale operations efficientlyJuly 2025 Macro Moves & AI Driven Price Predictions - khodrobank.com
What momentum shifts mean for MIRA Pharmaceuticals Inc.2025 Retail Activity & High Return Stock Watch Alerts - newser.com
Tick level data insight on MIRA Pharmaceuticals Inc. volatilityEarnings Growth Report & Stepwise Swing Trade Plans - newser.com
Statistical indicators supporting MIRA Pharmaceuticals Inc.’s strengthWeekly Profit Summary & Fast Gain Stock Tips - newser.com
Using RSI to spot recovery in MIRA Pharmaceuticals Inc.CEO Change & Reliable Price Action Trade Plans - newser.com
Short Squeeze: Can Coherus BioSciences Inc sustain its profitabilityPortfolio Performance Report & Risk Controlled Stock Pick Alerts - khodrobank.com
Trend Report: What is MIRA Pharmaceuticals Inc. s revenue forecast2025 Momentum Check & Verified Short-Term Plans - khodrobank.com
ETF Watch: What are MIRA Pharmaceuticals Incs recent SEC filings showingLong Setup & Free Safe Capital Growth Stock Tips - khodrobank.com
MIRA Pharmaceuticals’ Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin - Reno Gazette Journal
Aug Levels: Is Mega Matrix Inc forming a double bottomTake Profit & High Accuracy Investment Entry Signals - khodrobank.com
Entry Recap: Whats the outlook for MIRA Pharmaceuticals Incs sectorPortfolio Update Report & Weekly Watchlist of Top Performers - khodrobank.com
Momentum divergence signals in MIRA Pharmaceuticals Inc. chartMarket Growth Review & Fast Exit and Entry Trade Guides - newser.com
Update Report: What is the Moat Score of MIRA Pharmaceuticals IncJuly 2025 Movers & Daily Volume Surge Trade Alerts - خودرو بانک
Shorts Report: Can MIRA Pharmaceuticals Inc maintain its current growth rateJuly 2025 Trade Ideas & AI Driven Price Predictions - khodrobank.com
Loss Report: Is MIRA Pharmaceuticals Inc. a good stock for dollar cost averagingEarnings Summary Report & Long-Term Growth Portfolio Plans - خودرو بانک
Mira Pharmaceuticals Says Ketamir-2 Restores Normal Behavior in Stressed Rats - MarketScreener
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals - Rock Hill Herald
Breakthrough in PTSD Treatment: MIRA's Ketamir-2 Drug Reverses Stress Behaviors in Preclinical Study - Stock Titan
Volume Report: Whats the analyst consensus on The Gabelli Dividend Income TrustInsider Selling & Proven Capital Preservation Tips - خودرو بانک
Earnings Report: Is MIRA Pharmaceuticals Inc a strong growth stock2025 Trade Ideas & AI Powered Buy/Sell Recommendations - khodrobank.com
Chipmakers Recap: What is MIRA Pharmaceuticals Incs revenue forecast2025 Price Momentum & Free Low Drawdown Momentum Trade Ideas - خودرو بانک
MIRA Pharmaceuticals Reports Positive Ketamir-2 Study Results - TipRanks
Mira Pharmaceuticals reports positive PTSD data for Ketamir-2SEC filing - MarketScreener
Bear Alert: What are GLBZ’s technical support levelsWeekly Stock Recap & Reliable Price Breakout Signals - خودرو بانک
Multi asset correlation models including MIRA Pharmaceuticals Inc.2025 Breakouts & Breakdowns & Verified Momentum Stock Alerts - newser.com
Real time breakdown of MIRA Pharmaceuticals Inc. stock performanceJuly 2025 Update & Daily Chart Pattern Signals - newser.com
How to read the order book for MIRA Pharmaceuticals Inc.Quarterly Market Review & High Return Trade Opportunity Guides - newser.com
How to build a dashboard for OMAB stockJuly 2025 Selloffs & Breakout Confirmation Trade Signals - newser.com
Is MIRA Pharmaceuticals Inc. stock poised for growthTrade Analysis Report & Weekly Momentum Picks - Newser
Will MIRA Pharmaceuticals Inc. stock go up soonJuly 2025 Movers & Safe Capital Investment Plans - Newser
Quantitative breakdown of MIRA Pharmaceuticals Inc. recent moveWeekly Earnings Recap & Community Verified Trade Signals - Newser
Using data models to predict MIRA Pharmaceuticals Inc. stock movement2025 Support & Resistance & Intraday High Probability Setup Alerts - Newser
Pattern recognition hints at MIRA Pharmaceuticals Inc. upsideJuly 2025 Chart Watch & Advanced Swing Trade Entry Alerts - Newser
MIRA shareholders approve SKNY acquisition, adding obesity drug candidate - Investing.com
Using AI based signals to follow MIRA Pharmaceuticals Inc.Forecast Cut & Long-Term Growth Plans - Newser
MIRA Pharmaceuticals Shareholders Approve Acquisition of SKNY Pharmaceuticals, Advancing Next-Generation Oral Therapeutic for Obesity and Smoking Cessation - ACCESS Newswire
30% Weight Loss: MIRA Pharma's $30.5M SKNY Acquisition Targets $150B Obesity Drug Market - Stock Titan
Relative strength of MIRA Pharmaceuticals Inc. in sector analysisDividend Hike & Smart Allocation Stock Reports - Newser
Identifying reversal signals in MIRA Pharmaceuticals Inc.Portfolio Risk Report & AI Driven Stock Movement Reports - Newser
Mira Pharmaceuticals Inc (MIRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.08%
0.41%
자본화:
|
볼륨(24시간):